Sergliflozin-A is a selective inhibitor of sodium-glucose co-transporter proteins SGLT1 and SGLT2, which play key roles in glucose reabsorption in the kidney. By competitively inhibiting these transporters, Sergliflozin-A contributes to reduced glucose reabsorption, making it a valuable compound in the study and treatment of type 2 diabetes. Its efficacy may vary with different mutations in target sites, underscoring its potential for tailored therapeutic applications in metabolic disorders.
Sergliflozin-A is a selective inhibitor of sodium-glucose co-transporter proteins SGLT1 and SGLT2, which play key roles in glucose reabsorption in the kidney. By competitively inhibiting these transporters, Sergliflozin-A contributes to reduced glucose reabsorption, making it a valuable compound in the study and treatment of type 2 diabetes. Its efficacy may vary with different mutations in target sites, underscoring its potential for tailored therapeutic applications in metabolic disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
